Taro recalls skin treatment cream from US, Puerto Rico markets
- Elections 2014 LIVE: Modi files nomination from Vadodara; Ashutosh alleges threat by Sibal
- Its image dented, and spread too thin, Aam Aadmi Party struggles in Delhi
- Poll panel stares down Mamata
- Amit Shah CD doctored, BJP writes to poll panel
- BCCI moves SC to get access to statements by Srinivasan and Dhoni
Taro Pharmaceuticals, the Israel -based subsidiary of Sun Pharmaceuticals, has recalled nearly 40,000 tubes of Fluorouracil topical cream, used to treat various skin conditions, from the American market.
Taro Pharmaceuticals USA Inc has voluntarily recalled 39,982 tubes of Fluorouracil Topical Cream USP from the US and Puerto Rico markets, US Food and Drug Administration (USFDA) said in its enforcement report.
The reason for the class II recall is that 'product lacks stability', it added.
As per the USFDA, class II recalls are done in a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Sun Pharma had acquired a controlling stake in Taro in September, 2010. The Mumbai-based firm currently holds 66.5 per cent stake in Taro.
Topical fluorouracil is used to treat certain skin conditions in which cells are multiplying rapidly. It is used to treat cancerous or precancerous conditions including solar keratoses, actinic keratosis and superficial basal cell carcinoma.
- Walmart to launch 50 stores in big India push
- Poojary banking on ‘sympathy’ for Dakshina Kannada seat
- Solution to water woes key factor in Chikkaballapur
- Eying 85 pc turnout, election dept offers many sops
- Last day, last show: Parties flex muscles, try to connect with one & all
- From societies to slums, Adhalrao-Patil on the move